对比
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 vs 3q26q27 Microdeletion Syndrome C4755255
二者均为先天性疾病，但病因不同：前者是XX胎儿的内分泌性性发育异常，后者是染色体微缺失。现有资料未确立患病率、界值或预后。
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
A condition where hormones from the mother cross the placenta and cause atypical development in an XX fetus. It is present at birth. Management involves pediatric specialists and may include hormone therapy.
3q26q27 Microdeletion Syndrome C4755255
A genetic disorder from missing genetic material spanning 3q26 to 3q27, associated with developmental delays, growth concerns, and various medical features.
6 个对比维度
Onset
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Variable
3q26q27 Microdeletion Syndrome C4755255
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
severe
3q26q27 Microdeletion Syndrome C4755255
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
Chronic
3q26q27 Microdeletion Syndrome C4755255
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
No
3q26q27 Microdeletion Syndrome C4755255
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
reproductive
3q26q27 Microdeletion Syndrome C4755255
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
endocrine
3q26q27 Microdeletion Syndrome C4755255
genetic
Different category
结论
46-xx-disorder-of-sex-development-induced-by-endogenous-maternal-derived-androgen-C5679875 and 3q26q27-microdeletion-syndrome-C4755255 differ in severity, etiology
关键鉴别要点
在床旁或检查过程中最能可靠区分两种疾病的发现。
| 特征 | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3q26q27 Microdeletion Syndrome C4755255 | 鉴别力 |
|---|---|---|---|
| 机制 | 母体雄激素穿过胎盘并影响XX胎儿。 | 缺失跨越3q26至3q27的遗传物质。 | High |
| 主要表现 | 性发育不典型，通常在出生时发现。 | 发育迟缓、生长问题及多样医学特征。 | High |
| 临床类别 | 主要为生殖与内分泌问题。 | 先天性遗传疾病，特征范围更广。 | Moderate |
何时更支持某种疾病
选择 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 的情况
XX新生儿出现不典型外生殖器
符合所述母源性雄激素途径，但仍需确认。
Moderate
怀疑产前母体雄激素暴露
来源描述明确涉及母体激素穿过胎盘。
High
评估内分泌而非染色体缺失
所给类别为内分泌，不是染色体微缺失。
Moderate
选择 3q26q27 Microdeletion Syndrome C4755255 的情况
发育迟缓并有生长问题
这些是该微缺失综合征的主要描述特征。
Moderate
怀疑拷贝数变异
该病由3q26–q27遗传物质缺失定义。
High
无雄激素病史的多系统先天特征
较广泛表现可能提示遗传学评估，但不能排除重叠。
Low
关键检查差异
| 检查 | 46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875 | 3q26q27 Microdeletion Syndrome C4755255 | 解读 |
|---|---|---|---|
| 核型分析 | 若诊断成立，预期为46,XX。 | 常规核型可能无法发现微缺失。 | 仅凭核型不能确立任一诊断。 |
| 染色体微阵列 | 预期不会出现所述3q26q27缺失。 | 检查可能发现3q26–q27物质缺失。 | 检出缺失支持遗传诊断；未检出需临床判断。 |
| 雄激素评估 | 母体或胎儿雄激素评估可能相关。 | 雄激素检测不能定义该综合征。 | 异常结果只是发现，本身并非诊断。 |
预后对比
46 Xx Disorder Of Sex Development Induced By Endogenous Maternal Derived Androgen C5679875
- 转归
- 根据现有资料，长期结局尚未确立。
- 因素
- 雄激素影响程度和专科管理可能有关。
3q26q27 Microdeletion Syndrome C4755255
- 转归
- 病程为慢性且可变，确切预后尚未确立。
- 因素
- 缺失范围及相关发育或生长特征可能有关。
时间范围: 自出生或识别起，持续至儿童期照护。
检测确认、伴随表现以及能否获得适当专科服务。
并发症对比
| 并发症 | 表现 |
|---|---|
| 诊断不确定 | 仅凭外观不能确认内分泌原因。 特征变异可能延迟遗传学识别。 两者都需要专科确认。 |
| 相关照护需求 | 可能需要内分泌和生殖随访。 可能需要发育与生长支持。 具体并发症发生率尚未确立。 |
| 家庭影响 | 问题常涉及性发育和激素。 问题常涉及遗传、发育和生长。 咨询应个体化。 |
患者教育要点
- High病因不同
前者涉及XX胎儿受母体雄激素影响，后者涉及3号染色体物质缺失。
- High专科解读
应由儿科内分泌或遗传学专科解读结果。不要自行开始激素治疗。
- Medium证据限制
现有信息未确立患病率、实验室界值、死亡率或治疗剂量。